Clinical Trial Update: MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9) [Phase 1]

View source ↗

Summary

A Phase 1 MAD study of Cavosonstat (N91115) to assess safety, tolerability, and pharmacokinetics in healthy subjects has been completed; cystic fibrosis is list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cavosonstat (Cavosonstat)

Snippet

Sponsor: Nivalis Therapeutics, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED